Avior Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11
Closed -$219 2391
2024
Q1
$219 Buy
+11
New +$213 ﹤0.01% 2840
2023
Q1
Sell
-100
Closed -$2.71K 1632
2022
Q4
$2.71K Hold
100
﹤0.01% 1028
2022
Q3
$2K Hold
100
﹤0.01% 1013
2022
Q2
$2K Hold
100
﹤0.01% 931
2022
Q1
$3K Hold
100
﹤0.01% 939
2021
Q4
$3K Hold
100
﹤0.01% 933
2021
Q3
$3K Hold
100
﹤0.01% 892
2021
Q2
$3K Hold
100
﹤0.01% 859
2021
Q1
$4K Hold
100
﹤0.01% 846
2020
Q4
$4K Hold
100
﹤0.01% 799
2020
Q3
$3K Hold
100
﹤0.01% 781
2020
Q2
$2K Hold
100
﹤0.01% 785
2020
Q1
$2K Hold
100
﹤0.01% 676
2019
Q4
$3K Hold
100
﹤0.01% 686
2019
Q3
$3K Hold
100
﹤0.01% 646
2019
Q2
$4K Hold
100
﹤0.01% 661
2019
Q1
$4K Hold
100
﹤0.01% 579
2018
Q4
$4K Hold
100
﹤0.01% 626
2018
Q3
$7K Hold
100
﹤0.01% 603
2018
Q2
$6K Buy
+100
New +$5.28K ﹤0.01% 629

Other funds holding AVNS

Avior Wealth Management's AVNS Position: Q2 2024 in Review

Avior Wealth Management sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 11 shares — an estimated $219 sold.

Avior Wealth Management first reported a position in AVNS in Q2 2018 and held it in 20 quarters. The position peaked at $7K in Q3 2018. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Avior Wealth Management reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 11 Avanos Medical shares in Q2 2024, an estimated $219.
  • Avior Wealth Management first reported a position in Avanos Medical in Q2 2018 and held it in 20 quarters.
  • Avior Wealth Management's Avanos Medical position peaked at $7K in Q3 2018.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.